ACTICOAT◊ Site is an antimicrobial absorbent 3-layer dressing consisting of the following:
?A nanocrystalline silver-coated polyurethane wound contact layer
?a white polyurethane foam layer and
?a blue waterproof polyurethane film layer
The dressing provides an effective barrier to microbial contamination protecting the insertion site from invasive pathogenic microorganisms. Nanocrystalline silver is also effective against micro-organisms present in the wound.
ACTICOAT◊ Site is indicated as a dressing for use around vascular and non-vascular percutaneous device sites such as intravenous catheter insertion sites and external fixation sites. ACTICOAT◊ Site may be left in place for up to 7 days.
ACTICOAT◊ Site may be used on infected insertion sites. Where the product is used on infected insertion sites, the infection should be inspected and treated as per local clinical protocol.
.Contraindications / Precautions
?Do not use on patients with a known sensitivity to silver
?Do not use on patients with a known sensitivity to polyurethane
?Do not use on patients during MRI (Magnetic Resonance Imaging) examination because the image at the dressing site may be distorted
?For external use only
?ACTICOAT◊ Site is not compatible with oil-based products such as petrolatum
?ACTICOAT◊ Site may not be compatible with topical antimicrobials
?ACTICOAT◊ Site is not compatible with oxidising agents (eg. EUSOL) as these can breakdown the absorbent polyurethane component of the dressing
?Avoid contact with electrodes or conductive gels during electronic measurements eg. EEG and ECG
?Prior to administering radiation therapy, remove ACTICOAT◊ Site. A new dressing can be applied following treatment
?If reddening or sensitisation occurs, discontinue use
?ACTICOAT◊ Site should be removed prior to X-ray as it may obscure imaging
.Ordering Codes / Reimbursement Information
Product# Size Pcs/Pkg Pkg/Case HCPCS
20611 1 disk with 4mm central opening 10 10 A6209
Where required, cleansing of the skin using sterile water around the wound should be performed according to local clinical protocol. Saline should not be used.
Remove the ACTICOAT◊ Site dressing from the pack using an aseptic technique. The dressing should not be moistened prior to use.
Apply ACTICOAT◊ Site aseptically around the inserted device so that the device is completely surrounded by the dressing. The silver layer should be in contact with insertion site and the blue side of the dressing away from the skin.
Ensure that the pre-cut slit is oriented near or under the inserted device and that the edges of the slit meet to allow full contact with the surrounding skin.
Secure the dressing with an appropriate secondary retention dressing, e.g. IV3000◊.
Remove film dressing and ACTICOAT◊ Site dressing in one piece by stretching the film parallel to the patients skin while stabilising the the patients skin and catheter with hand. Alternatively, where using IV3000◊, use an alcohol wipe to break the adhesive seal.
?Only one dressing should be applied to the insertion site.
?Occasionally transient pain on application of ACTICOAT◊ has been reported. This can be minimised by carefully following the application instructions.
?Should continuous pain be experienced after application remove the dressing and discontinue use.
?The dressing may be left in place for up to 7 days, but will require earlier changing if a strike through of exudate occurs.
?If the dressing adheres to the insertion site, moisten or soak to assist removal and avoid disruption of the insertion site.
?ACTICOAT◊ Site may cause transient discolouration of the surrounding skin.